Resources

For more information or an introduction to any of these companies, e-mail sbecker@mcguirewoods.com or call (800) 417-2035. National trade associationsAccreditationAnesthesia staffing and managementBack-office management, outsourcing and accountingBilling, coding and collectingCataract outsourcingConsultation and brokerageCredentialingFinanceGroup purchasing organizationsHealth information technology providers Home health Hospital consulting Imaging Management, consulting and strategyManagement, development and equity firmsMedical devices – Surgical surplus […]

Advertisement
Resource type
All
Topics

Picture a radiology revenue cycle where prior authorization issues get caught before claims go out, documentation gaps get flagged in real time and denial trends actually inform the next intake conversation. That’s the operating model the strongest radiology RCM teams…

Presented by:

Presented by

Patient trust in healthcare has fallen sharply — only 24% of Americans now believe providers prioritize care over profits, down from 77% in December 2021. For a growing share of patients, that judgment is forming online, before they ever schedule…

Presented by:

Presented by

An underrecognized, genetically inherited risk factor may be quietly accelerating cardiovascular disease in patients you’re already treating — and routine workups won’t catch it. Lipoprotein(a), or Lp(a), has an emerging and increasingly documented role in aortic stenosis and peripheral arterial…

On Demand

Presented by:

Presented by

Presenters

Dr. Marc P. Bonaca MD, MPH, FACC, FAHA

Executive Director of Colorado Prevention Center, Aurora, CO, USA Director of Vascular Research, Tenured Professor of Medicine, University of Colorado Anschutz, Aurora, CO, USA Chair of the AHA PAD Collaborative Past Chair of the ACC Vascular Disease Section Leadership Council

Nishant Shah, MD

Assistant Professor, Medicine and Cardiovascular Disease Prevention Lead for the Duke Health System Remote Lipid Monitoring Program Clinical lead in the implementation of Inclisiran across Duke Health System DCRI for a study that evaluates the effectiveness of PCSK9 inhibitors in the Prevention of Cardiovascular Disease

As care delivery for rare cardiac diseases evolves, many health systems are working to establish more programmatic, systemwide approaches to recognition, diagnosis and management. But fragmentation across clinical decision pathways remains a persistent challenge. A December 2025 Becker’s Healthcare survey,…

Presented by:

Presented by

Operations leaders see the promise of AI in credentialing — faster onboarding, lower administrative burden, accelerated time to revenue. They also see the risk: AI doesn’t absorb liability. Healthcare organizations do. NCQA standards still require human oversight for committee review,…

Presented by:

Presented by

Lp(a) is one of the most clinically meaningful — and most under-tested — cardiovascular risk factors in routine practice. Inaccurate assays, inconsistent reporting standards and disparities in testing across patient populations leave many at-risk patients undiagnosed and undertreated. This on-demand…

On Demand

Presented by:

Presented by

Presenters

Howard S. Weintraub, MD, FACC, FAHA, FASPC

Clinical Professor of Medicine, NYU Grossman School of Medicine  Clinical Director, NYU Center for the Prevention of Cardiovascular Disease

Leslie J. Donato, Ph.D., D(ABCC)

Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic

Cancer care now stretches beyond the four walls of the hospital. Patients want infusions closer to home. Multi-state systems are balancing enterprise consistency with local nuance. Coordination across settings is becoming the make-or-break capability. This editorial briefing captures the forces…

Presented by:

Presented by

As health systems navigate 2026, leaders are balancing near-term performance with longer-term positioning. Shifts in care delivery, workforce dynamics, policy, and competition are reshaping where growth opportunities exist and where new constraints are emerging. We’ve created a set of ready-to-use…

Presented by:

Presented by

The healthcare supply chain has long been treated as a cost center. That framing is breaking down. Labor pressure, reimbursement cuts, supply disruption and margin volatility have made it clear that another round of contract renegotiation will not be enough.…

Presented by:

Presented by

Controlled substance waste is one of the most overlooked cost centers in hospital pharmacy. Each waste event represents not just a lost dose, but lost nursing time, compliance overhead and real diversion risk. A recent multi-site study quantified the problem:…

On Demand

Presented by:

Presented by

Presenters

Matthew Gimbar, PharmD

Senior Associate Director, Pharmacy Operations, University of Illinois Hospital and Health Sciences Syste

Paul Stranges, PharmD, MSHI, BCACP, AE-C, FCCP

Assistant Director, Opioid Stewardship & Drug Diversion, University of Illinois Hospital and Health Sciences System

John Hertig, PharmD, MS, CPPS, FASHP, FFIP

Founder and President, Hertig Healthcare Advising

Advertisement